Please select the option that best describes you:
Topics:
Radiation Oncology • Gastrointestinal Cancers
When would you opt to manage anal squamous cell carcinoma, HPV+ with surveillance vs adjuvant treatment following a trans-anal excision?
Particularly in the setting of "higher risk" features such as grade 3 and a negative, but close margin, would you still consider offering surveillance?
Answer from: Radiation Oncologist at Academic Institution
Never
Sign in or Register to read more